Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Genetics · Huntington's Disease

Can I Have a Child Without Passing on Huntington's Disease?

At a Glance

Yes, you can have biological children without passing on Huntington's disease. The most common method is using In Vitro Fertilization (IVF) combined with preimplantation genetic testing (PGT-M) to screen embryos for the HD mutation before pregnancy. Options also exist to have an HD-free child without learning your own genetic status.

Yes, it is entirely possible to have children without passing on the gene that causes Huntington’s disease (HD). Whether you already know you carry the gene mutation, you are at risk but have chosen not to be tested, or you are currently experiencing symptoms, there are established medical pathways to help you have a biological child free of HD.

IVF with Preimplantation Genetic Testing (PGT-M)

For many individuals who carry the gene for Huntington’s disease, the most common approach to having a biological child without passing on the condition is In Vitro Fertilization (IVF) combined with Preimplantation Genetic Testing for Monogenic disorders (PGT-M) [1][2].

PGT-M allows doctors to screen embryos for the specific HD gene mutation before a pregnancy is established.

  • Preparation Phase: Before starting IVF, the laboratory must build a custom genetic “probe” specific to your family’s unique genetic markers [3][4]. This process can take several weeks or months.
  • The IVF Cycle: You undergo a standard IVF cycle to create embryos in a laboratory.
  • Testing and Transfer: Scientists carefully remove a few cells from each embryo to test for the HD mutation. Only the embryos that do not carry the HD mutation are transferred to the uterus to achieve a pregnancy [1][2].

This method is considered a highly effective strategy to eliminate the risk of transmitting the disease to your children, bypassing the need to test a fetus during pregnancy [5]. Success rates for having a baby using PGT-M for genetic conditions are similar to standard IVF success rates for individuals of the same age [6].

What If You Don’t Want to Know Your Own Status?

Many people who have a parent with Huntington’s disease choose not to undergo predictive testing because they do not want to know if they will develop the disease. If you are in this position, you can still have biological children free of HD using specialized processes called non-disclosing PGT or exclusion testing [7][7]. About one-third of people seeking PGT for Huntington’s disease choose this route [8].

  1. Non-Disclosing PGT: The clinic tests your blood and learns your genetic status, but they keep the results entirely secret from you and your local medical team. They then create embryos, test them directly for the mutation, and only transfer the embryos that are HD-free. You remain unaware of whether you actually carry the gene or not [7][7].
  2. Exclusion Testing (Linkage Analysis): Instead of looking directly for the HD mutation, the lab compares the DNA of the embryos to the DNA of your parents (including the parent who has HD). The clinic identifies which chromosome you inherited from your affected parent and which you inherited from your unaffected parent. Any embryo that receives the chromosome linked to the affected grandparent is excluded from transfer [8][8]. Note: This requires DNA samples from the prospective grandparents, which can be a logistical hurdle if they have passed away and no DNA was banked, or if family dynamics prevent cooperation.

Important Considerations for Non-Disclosing Options:

  • Risk of “Indirect Disclosure”: If you undergo direct non-disclosing testing, you might accidentally deduce your status based on the math of your results. Because a gene carrier only passes the mutation to half of their embryos, noticing that exactly 100% of your embryos are approved strongly implies you do not carry the gene. Conversely, if roughly half are excluded, you might deduce you do carry it. Exclusion testing helps prevent this specific risk, as 50% of embryos are always excluded regardless of your actual status.
  • Discarding Healthy Embryos: In exclusion testing, an embryo is excluded simply if it inherits DNA from the affected grandparent. Because you only had a 50% chance of inheriting the gene yourself, up to half of the embryos discarded during exclusion testing might actually be completely free of HD.

Considerations for Symptomatic Individuals

If you already have an active diagnosis and are experiencing symptoms of Huntington’s disease, you can still pursue IVF. However, it is important to discuss with your medical team whether the physical demands and hormonal shifts of IVF medications or pregnancy might temporarily exacerbate early chorea, cognitive, or psychiatric symptoms. Additionally, some fertility clinics have specific policies regarding maternal health and neurological symptoms, making it important to consult a specialized clinic early in your family planning journey.

Other Family Planning Options

While PGT-M is highly effective, it is also costly, emotionally taxing, and physically demanding [9]. Other recognized options to prevent passing on HD include:

  • Prenatal Diagnosis: You can become pregnant naturally and test the fetus during early pregnancy using Chorionic Villus Sampling (CVS) or amniocentesis [1][10]. This option carries the difficult risk of deciding whether to terminate the pregnancy if the fetus tests positive for the mutation [8][8]. Note: If you do not know your own genetic status, testing the fetus carries an additional risk—if the fetus tests positive, it automatically reveals that you carry the gene as well. Furthermore, finding a provider to perform these tests might require early advocacy, as some clinics have varying policies on prenatal testing without a prior plan for the pregnancy.
  • Donor Gametes: Using sperm or eggs from a healthy donor completely removes the risk of passing on the HD gene, though it means the child will not be biologically related to one parent.
  • Adoption or Fostering: Many families choose to grow their families through non-biological pathways.

Financial and Support Considerations

Because these decisions are deeply personal, financially burdensome, and medically complex, professional guidelines strongly recommend meeting with a specialized genetic counselor who has experience with both Huntington’s disease and assisted reproductive technology [11][12]. IVF and PGT-M can be very expensive [9], and insurance coverage varies significantly. Many families seek out HD-specific advocacy organizations, such as the Huntington’s Disease Society of America (HDSA) or local equivalents, which often provide resources, guidance, and information on grants to help offset these costs. They can help you weigh the emotional, financial, and physical implications of each choice [13][14].

Common questions in this guide

Can I have an HD-free child if I don't know my own genetic status?
Yes. You can use non-disclosing IVF, where the clinic tests embryos but keeps your genetic status entirely secret from you. Another option is exclusion testing, which ensures the embryo didn't inherit the chromosome from the grandparent with Huntington's disease, though this requires DNA from family members.
What is PGT-M for Huntington's disease?
Preimplantation Genetic Testing for Monogenic disorders (PGT-M) is a specialized process used during IVF. It allows doctors to screen embryos in a laboratory for the specific Huntington's disease gene mutation, ensuring only embryos without the mutation are transferred to the uterus to achieve pregnancy.
What happens if I get pregnant naturally and want to test the fetus for HD?
If you become pregnant naturally, you can test the fetus during early pregnancy using Chorionic Villus Sampling (CVS) or amniocentesis. However, this means facing the difficult decision of whether to terminate the pregnancy if the fetus tests positive. Additionally, if you don't know your own HD status, a positive fetal test will reveal that you carry the gene.
Can I undergo IVF if I already have Huntington's disease symptoms?
Yes, you can still pursue IVF if you are experiencing symptoms. However, you should consult a specialized fertility clinic early, as you and your medical team will need to discuss whether the physical demands of IVF medications or pregnancy might temporarily worsen your early chorea, cognitive, or psychiatric symptoms.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does your fertility clinic have direct experience with PGT-M specifically for Huntington's disease, and what is your protocol for preventing indirect disclosure?
  2. 2.How long does it typically take your laboratory to build a custom genetic probe for an HD mutation before we can even begin a cycle?
  3. 3.What are the specific costs of IVF and PGT-M, and are there any HD-specific financial assistance programs or insurance pathways you recommend looking into?
  4. 4.If we choose exclusion testing, exactly which family members will need to provide DNA samples, and what happens if those individuals are unavailable?
  5. 5.Are there specific medical or symptom-related requirements for patients who have already been diagnosed with HD to safely undergo an IVF cycle and pregnancy?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Preimplantation genetics and other reproductive options in Huntington disease.

    Blancato JK, Wolfe EM, Sacks PC

    Handbook of clinical neurology 2017; (144()):107-111 doi:10.1016/B978-0-12-801893-4.00009-2.

    PMID: 28947109
  2. 2

    Preimplantation genetic testing for Huntington disease: the perspective of one Portuguese center.

    Ferreira D, Carvalho B, Neto AP, et al.

    Porto biomedical journal 2019; (4(5)):e48 doi:10.1097/j.pbj.0000000000000048.

    PMID: 31893246
  3. 3

    Robust Preimplantation Genetic Testing of Huntington Disease by Combined Triplet-Primed PCR Analysis of the HTT CAG Repeat and Multi-Microsatellite Haplotyping.

    Zhao M, Cheah FSH, Tan ASC, et al.

    Scientific reports 2019; (9(1)):16481 doi:10.1038/s41598-019-52769-3.

    PMID: 31712634
  4. 4

    Transfer of embryos with positive results following preimplantation genetic testing for monogenic disorders (PGT-M): experience of two high-volume fertility clinics.

    Besser AG, Blakemore JK, Grifo JA, Mounts EL

    Journal of assisted reproduction and genetics 2019; (36(9)):1949-1955 doi:10.1007/s10815-019-01538-2.

    PMID: 31359233
  5. 5

    In vitro fertilization with preimplantation genetic testing for monogenetic diseases versus unassisted conception with prenatal diagnosis for Huntington disease: a cost-effectiveness analysis.

    Christensen AA, Parker PB, Hersh AR, et al.

    Fertility and sterility 2022; (118(1)):56-64 doi:10.1016/j.fertnstert.2022.03.010.

    PMID: 35618525
  6. 6

    Experience of more than 100 preimplantation genetic diagnosis cycles for monogenetic diseases using whole genome amplification and linkage analysis in a single centre.

    Chow JF, Yeung WS, Lee VC, et al.

    Hong Kong medical journal = Xianggang yi xue za zhi 2015; (21(4)):299-303 doi:10.12809/hkmj144436.

    PMID: 26044869
  7. 7

    Non-disclosing preimplantation genetic diagnosis for Huntington disease.

    Stern HJ, Harton GL, Sisson ME, et al.

    Prenatal diagnosis 2002; (22(6)):503-7 doi:10.1002/pd.359.

    PMID: 12116316
  8. 8

    Preimplantation genetic diagnosis (PGD) for Huntington's disease: the experience of three European centres.

    Van Rij MC, De Rademaeker M, Moutou C, et al.

    European journal of human genetics : EJHG 2012; (20(4)):368-75 doi:10.1038/ejhg.2011.202.

    PMID: 22071896
  9. 9

    Utilization of preimplantation genetic testing for monogenic disorders.

    Lee I, Alur-Gupta S, Gallop R, Dokras A

    Fertility and sterility 2020; (114(4)):854-860 doi:10.1016/j.fertnstert.2020.05.045.

    PMID: 33040985
  10. 10

    27 years of prenatal diagnosis for Huntington disease in the United Kingdom.

    Piña-Aguilar RE, Simpson SA, Alshatti A, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2019; (21(7)):1639-1643 doi:10.1038/s41436-018-0367-z.

    PMID: 30546084
  11. 11

    Use of preimplantation genetic testing for monogenic defects (PGT-M) for adult-onset conditions: an Ethics Committee opinion.

    ,

    Fertility and sterility 2018; (109(6)):989-992 doi:10.1016/j.fertnstert.2018.04.003.

    PMID: 29935659
  12. 12

    Use of preimplantation genetic testing for monogenic adult-onset conditions: an Ethics Committee opinion.

    Fertility and sterility 2024; (122(4)):607-611 doi:10.1016/j.fertnstert.2024.05.165.

    PMID: 38944787
  13. 13

    Prenatal testing in Huntington disease: after the test, choices recommence.

    Bouchghoul H, Clément SF, Vauthier D, et al.

    European journal of human genetics : EJHG 2016; (24(11)):1535-1540 doi:10.1038/ejhg.2016.59.

    PMID: 27302844
  14. 14

    "I have to start learning how to live with becoming sick": A scoping review of the lived experiences of people with Huntington's disease.

    Mahmood S, Law S, Bombard Y

    Clinical genetics 2022; (101(1)):3-19 doi:10.1111/cge.14024.

    PMID: 34216010

This information regarding family planning and Huntington's disease is for educational purposes only and does not replace professional medical advice. Always consult with a genetic counselor or reproductive endocrinologist about your specific family planning options.

Get notified when new evidence is published on Huntington disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.